Primary progressive multiple sclerosis
5 papers study it3 more mention it
- Humans3
Trial sponsors
Company1 trialPhase 3656 people
Company1 trialPhase 1/2119 people
Company1 trialPhase 134 people
Copenhagen University Hospital, Rigshospitalet
1 trialPhase 3600 people
University of California Los Angeles
2 trialsPhase 287 people
1 trialPhase 2120 people
1 trialPhase 298 people
2 trialsPhase 1/2125 people
Latest
2 papers in 12 monthsJournal of Neurology
Distinct age-related pattern of mitochondrial somatic mutations across multiple sclerosis phenotypes
Cohort study of 404 peopleMitochondrion
Neurology(R) Neuroimmunology & Neuroinflammation
Proteomics Reveals Age as Major Modifier of Inflammatory CSF Signatures in Multiple Sclerosis
Cohort study of 60 peopleInflammation
bioRxiv
The mutational landscape of single neurons and oligodendrocytes reveals evidence of inflammation-associated DNA damage in multiple sclerosis
Preprint: case-control study in peopleDNA damage response
Experimental Biology and Medicine
Anti-inflammatory nutritional intervention in patients with relapsing-remitting and primary-progressive multiple sclerosis: A pilot study
Trial in peopleInterventions